Literature DB >> 35859134

Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study.

Yimin Zhao1, Yueying Li1, Zhenhuang Zhuang1, Zimin Song1, Wenxiu Wang1, Ninghao Huang1, Xue Dong1, Wendi Xiao1, Jinzhu Jia2, Zhonghua Liu3, Duo Li4,5, Tao Huang6,7,8.   

Abstract

AIM/HYPOTHESIS: We aimed to investigate the association between polysocial risk score (PsRS), an estimator of individual-level exposure to cumulative social risks, and incident type 2 diabetes in the UK Biobank study.
METHODS: This study includes 319,832 participants who were free of diabetes, cardiovascular disease and cancer at baseline in the UK Biobank study. The PsRS was calculated by counting the 12 social determinants of health from three social risk domains (namely socioeconomic status, psychosocial factors, and neighbourhood and living environment) that had a statistically significant association with incident type 2 diabetes after Bonferroni correction. A healthy lifestyle score was calculated using information on smoking status, alcohol intake, physical activity, diet quality and sleep quality. A genetic risk score was calculated using 403 SNPs that showed significant genome-wide associations with type 2 diabetes in people of European descent. The Cox proportional hazards model was used to analyse the association between the PsRS and incident type 2 diabetes.
RESULTS: During a median follow-up period of 8.7 years, 4427 participants were diagnosed with type 2 diabetes. After adjustment for major confounders, an intermediate PsRS (4-6) and high PsRS (≥7) was associated with higher risks of developing type 2 diabetes with the HRs being 1.38 (95% CI 1.26, 1.52) and 2.02 (95% CI 1.83, 2.22), respectively, compared with those with a low PsRS (≤3). In addition, an intermediate to high PsRS accounted for approximately 34% (95% CI 29, 39) of new-onset type 2 diabetes cases. A healthy lifestyle slightly, but significantly, mitigated PsRS-related risks of type 2 diabetes (pinteraction=0.030). In addition, the additive interactions between PsRS and genetic predisposition led to 15% (95% CI 13, 17; p<0.001) of new-onset type 2 diabetes cases (pinteraction<0.001). CONCLUSIONS/
INTERPRETATION: A higher PsRS was related to increased risks of type 2 diabetes. Adherence to a healthy lifestyle may attenuate elevated diabetes risks due to social vulnerability. Genetic susceptibility and disadvantaged social status may act synergistically, resulting in additional risks for type 2 diabetes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Genetic predisposition; Lifestyle; Polysocial risk score; Type 2 diabetes; UK Biobank

Year:  2022        PMID: 35859134     DOI: 10.1007/s00125-022-05761-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.460


  50 in total

Review 1.  Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes.

Authors:  Shona J Kelly; Mubarak Ismail
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

2.  Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries.

Authors:  Jacqueline A Seiglie; Maja-Emilia Marcus; Cara Ebert; Nikolaos Prodromidis; Pascal Geldsetzer; Michaela Theilmann; Kokou Agoudavi; Glennis Andall-Brereton; Krishna K Aryal; Brice Wilfried Bicaba; Pascal Bovet; Garry Brian; Maria Dorobantu; Gladwell Gathecha; Mongal Singh Gurung; David Guwatudde; Mohamed Msaidié; Corine Houehanou; Dismand Houinato; Jutta Mari Adelin Jorgensen; Gibson B Kagaruki; Khem B Karki; Demetre Labadarios; Joao S Martins; Mary T Mayige; Roy Wong-McClure; Joseph Kibachio Mwangi; Omar Mwalim; Bolormaa Norov; Sarah Quesnel-Crooks; Bahendeka K Silver; Lela Sturua; Lindiwe Tsabedze; Chea Stanford Wesseh; Andrew Stokes; Rifat Atun; Justine I Davies; Sebastian Vollmer; Till W Bärnighausen; Lindsay M Jaacks; James B Meigs; Deborah J Wexler; Jennifer Manne-Goehler
Journal:  Diabetes Care       Date:  2020-02-12       Impact factor: 19.112

Review 3.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

4.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.

Authors:  Anubha Mahajan; Daniel Taliun; Matthias Thurner; Neil R Robertson; Jason M Torres; N William Rayner; Anthony J Payne; Valgerdur Steinthorsdottir; Robert A Scott; Niels Grarup; James P Cook; Ellen M Schmidt; Matthias Wuttke; Chloé Sarnowski; Reedik Mägi; Jana Nano; Christian Gieger; Stella Trompet; Cécile Lecoeur; Michael H Preuss; Bram Peter Prins; Xiuqing Guo; Lawrence F Bielak; Jennifer E Below; Donald W Bowden; John Campbell Chambers; Young Jin Kim; Maggie C Y Ng; Lauren E Petty; Xueling Sim; Weihua Zhang; Amanda J Bennett; Jette Bork-Jensen; Chad M Brummett; Mickaël Canouil; Kai-Uwe Ec Kardt; Krista Fischer; Sharon L R Kardia; Florian Kronenberg; Kristi Läll; Ching-Ti Liu; Adam E Locke; Jian'an Luan; Ioanna Ntalla; Vibe Nylander; Sebastian Schönherr; Claudia Schurmann; Loïc Yengo; Erwin P Bottinger; Ivan Brandslund; Cramer Christensen; George Dedoussis; Jose C Florez; Ian Ford; Oscar H Franco; Timothy M Frayling; Vilmantas Giedraitis; Sophie Hackinger; Andrew T Hattersley; Christian Herder; M Arfan Ikram; Martin Ingelsson; Marit E Jørgensen; Torben Jørgensen; Jennifer Kriebel; Johanna Kuusisto; Symen Ligthart; Cecilia M Lindgren; Allan Linneberg; Valeriya Lyssenko; Vasiliki Mamakou; Thomas Meitinger; Karen L Mohlke; Andrew D Morris; Girish Nadkarni; James S Pankow; Annette Peters; Naveed Sattar; Alena Stančáková; Konstantin Strauch; Kent D Taylor; Barbara Thorand; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Jaakko Tuomilehto; Daniel R Witte; Josée Dupuis; Patricia A Peyser; Eleftheria Zeggini; Ruth J F Loos; Philippe Froguel; Erik Ingelsson; Lars Lind; Leif Groop; Markku Laakso; Francis S Collins; J Wouter Jukema; Colin N A Palmer; Harald Grallert; Andres Metspalu; Abbas Dehghan; Anna Köttgen; Goncalo R Abecasis; James B Meigs; Jerome I Rotter; Jonathan Marchini; Oluf Pedersen; Torben Hansen; Claudia Langenberg; Nicholas J Wareham; Kari Stefansson; Anna L Gloyn; Andrew P Morris; Michael Boehnke; Mark I McCarthy
Journal:  Nat Genet       Date:  2018-10-08       Impact factor: 38.330

5.  Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study.

Authors:  Monika M Safford; Evgeniya Reshetnyak; Madeline R Sterling; Joshua S Richman; Paul M Muntner; Raegan W Durant; John Booth; Laura C Pinheiro
Journal:  Circulation       Date:  2020-12-03       Impact factor: 29.690

6.  Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults.

Authors:  Rita Hamad; Joanne Penko; Dhruv S Kazi; Pamela Coxson; David Guzman; Pengxiao C Wei; Antoinette Mason; Emily A Wang; Lee Goldman; Kevin Fiscella; Kirsten Bibbins-Domingo
Journal:  JAMA Cardiol       Date:  2020-08-01       Impact factor: 14.676

7.  Globalization of diabetes: the role of diet, lifestyle, and genes.

Authors:  Frank B Hu
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

8.  Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records.

Authors:  Jonathan Pearson-Stuttard; Yiling J Cheng; James Bennett; Eszter P Vamos; Bin Zhou; Jonathan Valabhji; Amanda J Cross; Majid Ezzati; Edward W Gregg
Journal:  Lancet Diabetes Endocrinol       Date:  2021-11-30       Impact factor: 32.069

9.  The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study.

Authors:  Jedidiah I Morton; Jenni Ilomӓki; Dianna J Magliano; Jonathan E Shaw
Journal:  Diabetologia       Date:  2020-10-20       Impact factor: 10.122

10.  Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.

Authors:  Kyle J Gaulton; Teresa Ferreira; Yeji Lee; Anne Raimondo; Reedik Mägi; Michael E Reschen; Anubha Mahajan; Adam Locke; N William Rayner; Neil Robertson; Robert A Scott; Inga Prokopenko; Laura J Scott; Todd Green; Thomas Sparso; Dorothee Thuillier; Loic Yengo; Harald Grallert; Simone Wahl; Mattias Frånberg; Rona J Strawbridge; Hans Kestler; Himanshu Chheda; Lewin Eisele; Stefan Gustafsson; Valgerdur Steinthorsdottir; Gudmar Thorleifsson; Lu Qi; Lennart C Karssen; Elisabeth M van Leeuwen; Sara M Willems; Man Li; Han Chen; Christian Fuchsberger; Phoenix Kwan; Clement Ma; Michael Linderman; Yingchang Lu; Soren K Thomsen; Jana K Rundle; Nicola L Beer; Martijn van de Bunt; Anil Chalisey; Hyun Min Kang; Benjamin F Voight; Gonçalo R Abecasis; Peter Almgren; Damiano Baldassarre; Beverley Balkau; Rafn Benediktsson; Matthias Blüher; Heiner Boeing; Lori L Bonnycastle; Erwin P Bottinger; Noël P Burtt; Jason Carey; Guillaume Charpentier; Peter S Chines; Marilyn C Cornelis; David J Couper; Andrew T Crenshaw; Rob M van Dam; Alex S F Doney; Mozhgan Dorkhan; Sarah Edkins; Johan G Eriksson; Tonu Esko; Elodie Eury; João Fadista; Jason Flannick; Pierre Fontanillas; Caroline Fox; Paul W Franks; Karl Gertow; Christian Gieger; Bruna Gigante; Omri Gottesman; George B Grant; Niels Grarup; Christopher J Groves; Maija Hassinen; Christian T Have; Christian Herder; Oddgeir L Holmen; Astradur B Hreidarsson; Steve E Humphries; David J Hunter; Anne U Jackson; Anna Jonsson; Marit E Jørgensen; Torben Jørgensen; Wen-Hong L Kao; Nicola D Kerrison; Leena Kinnunen; Norman Klopp; Augustine Kong; Peter Kovacs; Peter Kraft; Jasmina Kravic; Cordelia Langford; Karin Leander; Liming Liang; Peter Lichtner; Cecilia M Lindgren; Eero Lindholm; Allan Linneberg; Ching-Ti Liu; Stéphane Lobbens; Jian'an Luan; Valeriya Lyssenko; Satu Männistö; Olga McLeod; Julia Meyer; Evelin Mihailov; Ghazala Mirza; Thomas W Mühleisen; Martina Müller-Nurasyid; Carmen Navarro; Markus M Nöthen; Nikolay N Oskolkov; Katharine R Owen; Domenico Palli; Sonali Pechlivanis; Leena Peltonen; John R B Perry; Carl G P Platou; Michael Roden; Douglas Ruderfer; Denis Rybin; Yvonne T van der Schouw; Bengt Sennblad; Gunnar Sigurðsson; Alena Stančáková; Gerald Steinbach; Petter Storm; Konstantin Strauch; Heather M Stringham; Qi Sun; Barbara Thorand; Emmi Tikkanen; Anke Tonjes; Joseph Trakalo; Elena Tremoli; Tiinamaija Tuomi; Roman Wennauer; Steven Wiltshire; Andrew R Wood; Eleftheria Zeggini; Ian Dunham; Ewan Birney; Lorenzo Pasquali; Jorge Ferrer; Ruth J F Loos; Josée Dupuis; Jose C Florez; Eric Boerwinkle; James S Pankow; Cornelia van Duijn; Eric Sijbrands; James B Meigs; Frank B Hu; Unnur Thorsteinsdottir; Kari Stefansson; Timo A Lakka; Rainer Rauramaa; Michael Stumvoll; Nancy L Pedersen; Lars Lind; Sirkka M Keinanen-Kiukaanniemi; Eeva Korpi-Hyövälti; Timo E Saaristo; Juha Saltevo; Johanna Kuusisto; Markku Laakso; Andres Metspalu; Raimund Erbel; Karl-Heinz Jöcke; Susanne Moebus; Samuli Ripatti; Veikko Salomaa; Erik Ingelsson; Bernhard O Boehm; Richard N Bergman; Francis S Collins; Karen L Mohlke; Heikki Koistinen; Jaakko Tuomilehto; Kristian Hveem; Inger Njølstad; Panagiotis Deloukas; Peter J Donnelly; Timothy M Frayling; Andrew T Hattersley; Ulf de Faire; Anders Hamsten; Thomas Illig; Annette Peters; Stephane Cauchi; Rob Sladek; Philippe Froguel; Torben Hansen; Oluf Pedersen; Andrew D Morris; Collin N A Palmer; Sekar Kathiresan; Olle Melander; Peter M Nilsson; Leif C Groop; Inês Barroso; Claudia Langenberg; Nicholas J Wareham; Christopher A O'Callaghan; Anna L Gloyn; David Altshuler; Michael Boehnke; Tanya M Teslovich; Mark I McCarthy; Andrew P Morris
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.